openPR Logo
Press release

Influenza B Infection Market- Present Scenario and Growth Prospects 2017 - 2025

10-26-2017 01:11 PM CET | Health & Medicine

Press release from: TMR Research

/ PR Agency: TMR Research
Influenza B Infection Market- Present Scenario and Growth

Global Influenza B Infection Market: Snapshot

Influenza B infection is considered as one of the common conditions that affects a large number of people across the globe, caused due to the influenza virus B genera of the family. The condition of influenza B infection requires proper medications and treatments in order to avoid severe complications. At present, several medicines and vaccinations are made available in order to reduce the incidence of influenza B infection across the globe. The increasing number of initiatives taken governments and NGOs to create an awareness among people regarding this condition is projected to accelerate the growth of the global market in the next few years.

The prominent players operating in the global influenza B infection market are focusing on the development and new and effective therapeutics so as to reach a large number of patients across the globe. This is projected to offer promising growth opportunities in the next few years. In addition, the increasing expenditure on the development of the healthcare facilities, especially in developing economies are likely to accelerate the growth of the global influenza B infection market in the coming few years.

Request Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=290

The presence of a huge number of players in the global market with a strong drug pipeline and the rising emphasis on clinical trials are estimated to develop the competitive scenario of the global influenza B infection market in the coming years. Moreover, the easy availability of drugs is predicted to supplement the growth of the overall market in the near future. With these factors, the global market for influenza B infection is projected to experience a high growth over the forecast period.

Global Influenza B Infection Market: Overview

Influenza is commonly classified as type A, B, or C, depending on the protein composition of the virus. Influenza B infection is caused by influenzavirus B genera of the family Orthomyxoviridae and is found only in humans. Common symptoms of the infection include runny nose, chills, fever, muscle pain, sore throat, fatigue, coughing, and general weakness. Nausea and vomiting is also observed in some cases, particularly in children. Frequent hand washing, wearing masks to prevent transmission, routine annual vaccination, and practicing good respiratory hygiene are the few ways that can help reduce the risk of people catching the infection. Vaccination offers a good protection against influenza B infection and is also important for people in high risk regions.

Request TOC of the Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=290

Global Influenza B Infection Market: Scope of Diagnostics

Symptoms of the infection if not treated on time may lead to complications such as bacterial pneumonia, myositis, encephalitis, Reyes’ syndrome, and sinus and ear infections. The infection is transmitted via air, by sneezing or coughing. Children are highly susceptible to the influenza B infection though it is also known to affect a substantial number of adults. Influenza B virus can be further broken down into different strains and lineages. Currently, two lineages identified include B/Victoria/2/87-like and B/Yamagata/16/88-like. Diagnosis of the infection is generally carried out by observing the symptoms. Laboratory testing is recommended in certain cases such as influenza outbreak and patients with high risk of complications.

Global Influenza B Infection Market: Core Segmentations

The global influenza B infections market can be segmented based on drug class, pipeline assessment and geography. Histopathological examinations help in assessing airway, and tissues of lung, heart, and lymph node for determining influenze B infection. Various molecules under pipeline for treating influenza B infections are BTL- TML001, favipiravir, and CR-9114. The World Health Organization (WHO) and the U.S. Center for Disease Control and Prevention recommend influenza vaccines for individuals with high risk such as healthcare workers, the elderly population, children and people suffering from chronic diseases such as diabetes, asthmatics, and heart disorder patients. Influenza vaccines are commonly administered as injection or nasal spray.

Get Discount @ https://www.tmrresearch.com/sample/sample?flag=D&rep_id=290

Antiviral drugs of class M2 protein inhibitors such as adamantine derivatives and neuraminidase inhibitors including zanamivir and oseltamivir are generally used to treat the infection. Zanamivir and oseltamivir help shorten the duration of the infection and also lower the risk of development of additional complications, though these drugs cause mild side-effects such as nausea and vomiting. Recent studies suggest that antiviral drugs such as amantadine and rimantadine are no longer effective due to generation of resistance by influenza virus. Home remedies include fluid intake, rest and over-the-counter painkillers. Acetaminophen helps in relieving headache, muscle ache and fever. However, aspirin is contraindicated since it increases the risk of Reyes’ syndrome. Antibiotics are recommended only in cases of bacterial complications and are also known to cause side effects and development of antibiotic resistance. Various other alternative treatments include homeopathic and herbal medicines though their safety and efficacy is yet under evaluation.

Global Influenza B Infection Market: Competitive Landscape

Geographically, the global influenza B infection market can be categorized into North America, Europe, Asia Pacific and Rest of the World. Yearly, approximately 200,000 people in the U.S. need to be hospitalized due to complications related to flu.

Some of the key players contributing to the global influenza B infections market have been AltraVax, Inc., Autoimmune Technologies, LLC, Crucell N.V., Chimerix, Inc., REPLICor, Inc., Humabs BioMed SA, ContraFect Corporation, and Takeda Pharmaceutical Company Limited.

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Our savvy custom-built reports span a gamut of industries such as pharmaceuticals, chemicals and metals, food and beverages, and technology and media, among others. With actionable insights uncovered through in-depth research of the market, we try to bring about game-changing success for our clients.

Contact:

TMR Research,

3739 Balboa St # 1097,

San Francisco, CA 94121

United States

Tel: +1-415-520-1050

Email: sales@tmrresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Influenza B Infection Market- Present Scenario and Growth Prospects 2017 - 2025 here

News-ID: 788059 • Views: 109

More Releases from TMR Research

Global Private LTE Market Analysis by Market Key Player, Product Application & G …
Global Private LTE Market: Overview The global private LTE market likely to registers significant growth during the course of forecast period from the period between 2018 till 2028. Moreover, this network provides the better alternatives of the public networks on account of high operational efficiency, low cost deployment and improved business application in terms of security. The private LTE market also provide more capacity and coverage and has facility to modify
Crude Sulfate Turpentine Market 2025 Harting S.A., Arizona Chemical Company LLC, …
Global Crude Sulfate Turpentine Market: Snapshot The global market for crude sulfate turpentine is growing at a robust pace and is likely to witness significant growth in the coming years. The increasing use of crude sulfate turpentine in diverse applications is expected to encourage the growth of the global market in the coming years. In addition, the rising demand for high-value products for personal care, especially in developing economies is likely
Wood Vinegar Market 2017 Analysis, Growth, Vendors, Shares, Drivers, Challenges …
Global Wood Vinegar Market: Snapshot Pyroligneous acid, commonly known as wood vinegar, is created from wood and plant materials, using a process known as destructive distillation. The core ingredients of wood vinegar include acetone, methanol, and acetic acid, and was historically used to produce acetic acid on large scales. Currently, the scope of use of wood vinegar stretches across a large number of application segments. One of the more common uses
Meat Processing Equipment Market 2025 | Key Technology Inc., JBT Corporation, Ma …
Global Meat Processing Equipment Market: Snapshot Changing food preferences, lifestyles, tastes, and habits of the global population have bolstered the growth of the market for meat processing equipment. Developing economies such as China and India have been exhibiting enormous demand for meat over the last few decades. Industrialization, growing urbanization, Western influence on the food habits of Eastern consumers, and the growing disposable incomes of people have offset the growth of

All 5 Releases


More Releases for Influenza

Influenza Diagnostics Market – Screening Product Awareness 2025
Global Influenza Diagnostics Market: Snapshot The global market for influenza diagnostics is slated to expand at a promising pace in the next few years as the incidences of influence are rising at a massive pace on the globe front. A common illness of the respiratory system, the condition is responsible for between 250,000 to 500,000 deaths across the globe every year. As the virulent spread of the condition creates increased concerns
Influenza B Infection Market Endeavors Growth 2025
Global Influenza B Infection Market: Snapshot Influenza B infection is considered as one of the common conditions that affects a large number of people across the globe, caused due to the influenza virus B genera of the family. The condition of influenza B infection requires proper medications and treatments in order to avoid severe complications. At present, several medicines and vaccinations are made available in order to reduce the incidence of
Influenza Diagnostics Market
Influenza, commonly known as flu, is an infectious disease caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Influenza spreads through infectious respiratory secretions caused by aerosol formation due to direct contact with an infected person. This virus can cause seasonal epidemics with high levels of morbidity and mortality. According to WHO, these epidemics were estimated to result in about
Uprising European Influenza Vaccine Market- Ken Research
Europe is at the heart of global vaccine research and production. Influenza is a vaccine preventable disease and influenza vaccine has been available for use in Europe since 1960’s. Approximately, at US$ 1 billion, Europe influenza market was closed. Nevertheless, the highest influenza market share was held by United Kingdom. West Europe has more than US$ 500 Million. United Kingdom, Germany, France, Italy and Spain hold 80 percent of influenza market
Global Influenza Vaccine Market Forecast
Global Influenza Vaccine Market is worth more than US$ 5 Billion. Globally Pediatrics Influenza Vaccinated Population was more than 150 Thousand, but still this figure was significantly less than the Adult Influenza Vaccinated Population. As per our research Pediatrics Influenza Vaccinated population will decline in future and Adult Influenza Vaccinated Population will increase in forecast period. United States has the highest market share in Influenza Vaccine Market. United States Influenza Vaccine
Influenza Diagnostics Market Analysis – 2024
Influenza, commonly known as flu, is an infectious disease caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Influenza spreads through infectious respiratory secretions caused by aerosol formation due to direct contact with an infected person. This virus can cause seasonal epidemics with high levels of morbidity and mortality. According to WHO, these epidemics were estimated to result in about